Product News
Thermo Fisher Scientific Introduces Animal Origin-Free Formulation To Support Scaling of Cell Therapy Manufacturing
Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.
Product News
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership To Accelerate Oligonucleotide Therapeutics Development
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
Product News
Patent Submission for Optimer® Binders in Cosmetic Products
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has filed a patent application to protect the recently developed Optimer binder sequences for novel applications.
Product News
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis
Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting educational presentations and showcasing live lab demos for customers working in laboratory technology, analysis, biotechnology, and environmental quality.
Product News
Autolomous and BioCentriq Partner To Speed Up Cell Therapy Delivery
Collaboration leverages cutting-edge digital platform to streamline development and manufacturing activities and speed patient access to life-changing treatments.
Product News
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis
Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.
Product News
Thermo Fisher Scientific Launches New ENERGY STAR Certified TSX Universal Series ULT Freezers
Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory.
Product News
Sterilis Solutions and Polycarbin Partner To Close the Loop for Treated Regulated Medical Waste Plastics
Sterilis Solutions and Polycarbin proudly announce their strategic partnership aimed at enhancing sustainability in laboratory waste management.
Product News
OrganaBio Launches On-Demand GMP-Compliant Hematopoietic Stem Cell Source for Advanced Therapy Manufacturing
First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.
Product News
Therapeutic Potential of CD20 X CD3 Bispecific Antibodies
As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Advertisement